● Recruiting

Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

Condition: Rectal Adenocarcinoma · Sponsor: Institut Paoli-Calmettes

PhaseN/A

Planned participants39

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

feasibility of using a diffusion sequence of a MRgRT system as an early marker of treatment response during nRCT of rectal adenocarcinoma.

This description comes directly from the study's public registry record.

Talk to the study team

Dominique GENRE, MD · 33491223778 · DRCI.UP@ipc.unicancer.fr

Margot BERLINE, MSc, MBA · 33491223778 · DRCI.UP@ipc.unicancer.fr

Always discuss trial participation with your own doctor first.

Locations (2)

University of California Los Angeles (UCLA)	Los Angeles, California, United States	Not Yet Recruiting
Institut Paoli Calmettes	Marseille, Bouches Du Rhone, France	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03961776